We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Waters and Imperial College London Expand Systems Biology Collaboration

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Waters and Imperial College London Expand Systems Biology Collaboration"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Waters Corporation has announced that it will expand its research collaboration with Imperial College London by equipping the Waters Laboratory of Molecular Spectroscopy at Imperial College London with three high-end research instruments - the Waters® ACQUITY UPLC™ System, and Waters Q-Tof Premier™ and GCT Premier ™ Mass Spectrometers.

The announcement was made as Imperial unveiled an NMR facility incorporating the mass spectrometry-based Waters Laboratory of Molecular Spectroscopy.

This laboratory will allow the Division of Molecular Biosciences to leverage a unique alignment of instrumental resources - mass spectrometry, high-resolution separations technologies, and nuclear magnetic resonance technology - to drive broad research programs in the important area of systems biology.

Art Caputo, President of the Waters Division, attended the official ceremony hosted by Imperial College inaugurating the laboratory.

The collaboration and new facility will allow researchers at Waters and Imperial to address fundamental medicinal-biology problems, which in turn will pave the way for a better understanding of the underlying causes of disease and the effect of lifestyle and diet on health and overall well-being.

It is hoped that the work done at this laboratory will provide the tools necessary to make significant steps toward the goal of personalized medicine.

Thanking Waters Corporation for their support, Jeremy Nicholson head of Imperial’s Department of Biomolecular Medicine said, "I’m delighted to welcome Arthur Caputo and his colleagues from Waters Corporation."

"Their investment in the new mass spectrometry laboratory - together with our new NMR facility - means that the College has a uniquely powerful new facility for molecular structure elucidation, which will enable researchers here in the future to develop new disease diagnostics based on small molecule biomarkers and to understand molecular mechanisms of disease."

"For the last four years Waters has enjoyed a strong relationship with Imperial College London," said Art Caputo, President of the Waters Division.

"During that time, we have worked on honing our expertise in the area of chemometric data analysis for metabonomics and biomedical applications and worked on strategies for creating more useful liquid chromatography and mass spectrometry tools for systems biology and structural characterization of biomolecules."

"We are delighted to be able to assist in continuing the important biological research with them and look forward to building on this relationship in the future."